A logo of China's vaccine specialist CanSino Biologics Inc is pictured on the company's headquarters in Tianjin, following an outbreak of the coronavirus disease (COVID-19), China August 17, 2020. REUTERS/Thomas Peter/File Photo
An inhalation version of CanSino Biologics' (6185.HK), COVID-19 vaccine is being tested in a Phase II clinical trial, Chief Executive Yu Xuefeng said late on Wednesday.
Yu made the comment at a panel of the Global Health Forum of the Boao Forum for Asia.
Our Standards: The Thomson Reuters Trust Principles.
"stage" - Google News
June 02, 2021 at 08:08PM
https://ift.tt/2S7UP69
CanSinoBIO's inhalation COVID-19 shot in mid-stage trial, says CEO - Reuters
"stage" - Google News
https://ift.tt/2xC8vfG
https://ift.tt/2KXEObV
Bagikan Berita Ini
0 Response to "CanSinoBIO's inhalation COVID-19 shot in mid-stage trial, says CEO - Reuters"
Post a Comment